Board of Scientific Counselors, National Center for Health Statistics, 48438 [2013-19156]
Download as PDF
<![CDATA[
48438
Federal Register / Vol. 78, No. 153 / Thursday, August 8, 2013 / Notices
Darius Taylor,
Deputy, Information Collection Clearance
Officer.
[FR Doc. 2013–19137 Filed 8–7–13; 8:45 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Board of Scientific Counselors,
National Center for Health Statistics
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following meeting of the
aforementioned committee:
Times and Dates:
11:00 a.m.–5:30 p.m., September 19,
2013
8:30 a.m.–1:00 p.m., September 20, 2013
Place: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
Status: This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. For foreign nationals or
non-US citizens, pre-approval is
required (please contact Gwen Mustaf,
301–458–4500, glm4@cdc.gov or
Virginia Cain, vcain@cdc.gov at least 10
days in advance for requirements). All
visitors are required to present a valid
form of picture identification issued by
a state, federal or international
government. As required by the Federal
Property Management Regulations, Title
41, Code of Federal Regulation, Subpart
101–20.301, all persons entering in or
on Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. The meeting room
accommodates approximately 100
people.
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters to be Discussed: The agenda
will include welcome remarks by the
VerDate Mar<15>2010
16:55 Aug 07, 2013
Jkt 229001
Acting Director, NCHS; Demo of the
NHIS Online Analytic Real-time System
(OARS); initiation of Office of Analysis
and Epidemiology review.
Requests to make oral presentations
should be submitted in writing to the
contact person listed below. All requests
must contain the name, address,
telephone number, and organizational
affiliation of the presenter.
Written comments should not exceed
five single-spaced typed pages in length
and must be received by September 4,
2013.
The agenda items are subject to
change as priorities dictate.
Contact Person for more Information:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 7208, Hyattsville,
Maryland 20782, telephone (301) 458–
4500, fax (301) 458–4020.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both Centers
for Disease Control and Prevention and
the Agency for Toxic Substances and
Disease Registry.
Elaine L. Baker,
Management Analysis and Services Office,
Centers for Disease Control and Prevention.
[FR Doc. 2013–19156 Filed 8–7–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0001]
Pediatric Ethics Subcommittee of the
Pediatric Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a subcommittee of a public
advisory committee of the Food and
Drug Administration (FDA). The
meeting will be open to the public.
Name of Subcommittee: Pediatric
Ethics Subcommittee of the Pediatric
Advisory Committee.
General Function of the
Subcommittee: To advise and make
recommendations to the Pediatric
Advisory Committee on pediatric
ethical issues.
Date and Time: The meeting will be
held on September 9, 2013, from 8 a.m.
to 5:30 p.m. and September 10, 2013,
from 8 a.m. to 3 p.m.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Location: Doubletree Hilton Hotel,
8727 Colesville Rd., Silver Spring, MD
20910, 301–589–5200 or visit the hotel’s
Web site at https://
doubletree3.hilton.com/en/hotels/
maryland/doubletree-by-hilton-hotelwashington-dc-silver-spring-DCASSDT/
index.html.
Contact Person: Walter Ellenberg,
Office of the Commissioner, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, rm. 5154,
Silver Spring, MD 20993, 301–796–
0885, email
walter.ellenberg@fda.hhs.gov or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
Federal Register about last minute
modifications that impact a previously
announced subcommittee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
Agenda: On September 9 and 10,
2013, the Pediatric Ethics Subcommittee
of the Pediatric Advisory Committee
will meet to discuss ethical issues in
pediatric product development,
including medical counter measures,
focusing on the concepts of minimal
risk, disorder or condition, and
exposure of pediatric subjects to risks
under 21 CFR 50.54.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the subcommittee meeting,
and the background material will be
posted on FDA’s Web site after the
meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before September 9, 2013.
Oral presentations from the public will
be scheduled between approximately 2
p.m. and 3 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 78, Number 153 (Thursday, August 8, 2013)]
[Notices]
[Page 48438]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19156]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Health
Statistics
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), National Center for Health Statistics (NCHS)
announces the following meeting of the aforementioned committee:
Times and Dates:
11:00 a.m.-5:30 p.m., September 19, 2013
8:30 a.m.-1:00 p.m., September 20, 2013
Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland
20782.
Status: This meeting is open to the public; however, visitors must
be processed in accordance with established federal policies and
procedures. For foreign nationals or non-US citizens, pre-approval is
required (please contact Gwen Mustaf, 301-458-4500, glm4@cdc.gov or
Virginia Cain, vcain@cdc.gov at least 10 days in advance for
requirements). All visitors are required to present a valid form of
picture identification issued by a state, federal or international
government. As required by the Federal Property Management Regulations,
Title 41, Code of Federal Regulation, Subpart 101-20.301, all persons
entering in or on Federal controlled property and their packages,
briefcases, and other containers in their immediate possession are
subject to being x-rayed and inspected. Federal law prohibits the
knowing possession or the causing to be present of firearms, explosives
and other dangerous weapons and illegal substances. The meeting room
accommodates approximately 100 people.
Purpose: This committee is charged with providing advice and making
recommendations to the Secretary, Department of Health and Human
Services; the Director, CDC; and the Director, NCHS, regarding the
scientific and technical program goals and objectives, strategies, and
priorities of NCHS.
Matters to be Discussed: The agenda will include welcome remarks by
the Acting Director, NCHS; Demo of the NHIS Online Analytic Real-time
System (OARS); initiation of Office of Analysis and Epidemiology
review.
Requests to make oral presentations should be submitted in writing
to the contact person listed below. All requests must contain the name,
address, telephone number, and organizational affiliation of the
presenter.
Written comments should not exceed five single-spaced typed pages
in length and must be received by September 4, 2013.
The agenda items are subject to change as priorities dictate.
Contact Person for more Information: Virginia S. Cain, Ph.D.,
Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 7208,
Hyattsville, Maryland 20782, telephone (301) 458-4500, fax (301) 458-
4020.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Management Analysis and Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013-19156 Filed 8-7-13; 8:45 am]
BILLING CODE 4163-18-P
